Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Latisha Doty and Alison Bocking have each lost more than 100 lbs. in the last two years—and gained a lifelong friend in the ...

The health risks of too much sugar have been made clear, but the billion-dollar global market to supply it is thriving. Sales of sweet treats remain strong, and waistlines keep expanding. Could weight ...

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

Novo Nordisk retains a strong market position in a high-growth industry, with P/E multiples poised to expand. See why NVO ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

With the soaring popularity of drugs like Ozempic, the market is ripe for disruption,” researcher Rubina Aktar said.

Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...

The FDA rejected sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control in adults with type 1 ...

Donald Trump's Secretary of Health Robert F. Kennedy Jr. wants Americans to eat healthier, but some of his MAGA colleagues ...

What a year! What do you think was the most important news in the United States in 2024? This list probably doesn’t reflect ...